Terence Mandable
Neuralink patient
25

Terence Mandable

Bulbar-onset ALS
VOICE
Patient
#
25
Implant date

2026

Condition
Bulbar-onset ALS
Study
VOICE
Hospital
UT Southwestern
Dallas, Texas, USA

* Likely, but not yet confirmed by Neuralink, the patient, or the trial site.

In their words
About
Terence Mandable

Terence (Terry) Mandable is Neuralink patient 25 and the third participant in the VOICE trial, which tests whether the implant can restore speech. He was diagnosed with bulbar-onset ALS in 2024, a form of the disease that takes speech first while the arms and legs keep working. He received his implant at UT Southwestern in Dallas, and it is in the speech motor region with 3,000 channels. In September 2026 Neuralink shared video of him telling his wife "I love you" in a voice decoded from his brain and rebuilt from recordings made before ALS, and CBS Evening News covered his story.

Neura Pod interview
Watch the full conversation on the Neura Pod YouTube channel.
Implant timeline

    Patient details come from the patient's own public posts, Neuralink, trial sites, and news reports. This page is general information about an investigational device and is not medical advice.

    Other patients

    Keep reading

    Also implanted at this hospital

    About this site

    Other Neuralink patients

    More publicly identified Neuralink patients